Company Profiles

driven by the PitchBook Platform

AlveoliX

Description

Developer of an in-vitro lung model for drug testing. The company helps in mimicking the biophysical characterstics of the lung. It also predicts the effects of respiratory drug candidates in humans and thus reduces the number of candidates to be tested in clinical trials.

PRIVATE

Status

Seed

Latest Deal Type

$20k

Latest Deal Amount

$20k

Total Amount Raised

1

Investors

Description

Developer of an in-vitro lung model for drug testing. The company helps in mimicking the biophysical characterstics of the lung. It also predicts the effects of respiratory drug candidates in humans and thus reduces the number of candidates to be tested in clinical trials.

Ownership Status

Privately held (backing)

Financing Status

Accelerator/Incubator Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Primary Office

Murtenstrasse 50 3010 BernSwitzerland
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore AlveoliX's full profile, request a free trial.

    AlveoliX Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    AlveoliX Investors (1)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Venture kickAccelerator/IncubatorMinority000 0000000 0000
    Venture kick Accelerator/Incubator

    AlveoliX Executive Team (1)

    NameTitleBoard
    Seat
    Contact
    Info
    Olivier GuenatFounder
    Olivier Guenat Founder
    Request full access to PitchBook